DuoGenic StemCells corporation (TPEX:7607)
Taiwan · Delayed Price · Currency is TWD 14.65
+0.15 (1.03%)
Jun 15, 2026, 12:22 PM CST
TPEX:7607 Market Cap
TPEX:7607 has a market cap or net worth of 443.02 million as of June 12, 2026. Its market cap has increased by 3.20% in one year.
Market Cap
443.02M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
14.65
Market Cap Chart
Since May 25, 2023, TPEX:7607's market cap has decreased from 1.92B to 443.02M, a decrease of -76.98%. That is a compound annual growth rate of -38.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 443.02M | -21.41% |
| Dec 31, 2025 | 563.70M | -20.13% |
| Dec 31, 2024 | 705.77M | -35.83% |
| Dec 22, 2023 | 1.10B | -42.86% |
| May 25, 2023 | 1.92B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 352.67B |
| Caliway Biopharmaceuticals | 144.28B |
| Heron Neutron Medical | 54.50B |
| Lotus Pharmaceutical | 51.64B |
| LAUNXP Biomedical | 541.99M |
| Sunder Biomedical Tech. | 466.20M |
| UniPharma | 413.59M |
| Pharmigene | 410.79M |